Drawing for HTL

USPTO serial 79256282

HTL

Reviewed by CopyMark Law Group

Reg. 5980276Status 706Registered
Filing date
Status date
Registration date
Feb 11, 2020
Examiner
LAPTER, ALAIN J
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with HTL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Philip L. Conrad

Philip L. Conrad DECODE LEGAL INC.560 Cremazie Boul. East, 3rd floorMontreal (Quebec), H2P1E8CANADA

Goods and services

ClassDescriptionStatusFirst use
001Chemical products for industrial and scientific purposes, namely, chemical preparations for scientific purposes and chemical preparations for use in industry, raw chemical materials for industry and science, namely, biological polymersACTIVE—
003Cosmetic products for skin care, namely, skin creams, serums, lotions and solutions containing hyaluronic acid and derivatives, heparosan, chondroitin, or other glycosaminoglycans, skin tanning creams and lotions, cosmetic preparations for slimming purposes, products for nail, hair and teeth care, namely, creams, serums, lotions and solutions containing hyaluronic acid and derivatives, heparosan, chondroitin, or other glycosaminoglycansACTIVE—
005Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations that are in injectable or non-injectable form for the treatment of dermatological, rheumatological, ophthalmological diseases, disorders and conditions, and for use in regenerative medicine and for treatment or augmentation of bone and tissue, chemical preparations for medical and veterinary use, namely, for the treatment of dermatological, rheumatological, ophthalmological diseases, disorders and conditions, and for use in regenerative medicine and for treatment or augmentation of bone and tissueACTIVE—
042Industrial analysis and research in the field of pharmaceutical products, healthcare products, and medical devices containing hyaluronic acid and derivatives, and other biopolymers of medical interest, research and development of new preparations for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jun 9, 202671AGREGISTERED-SEC.71 ACCEPTED—
Jun 1, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 11, 2026ES71TEAS SECTION 71 RECEIVED—
Feb 4, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 4, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 4, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 4, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 4, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 4, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 11, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 19, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 1, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 31, 2020FIMPFINAL DISPOSITION PROCESSED—
May 11, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 11, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 26, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 26, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 6, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 20, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 15, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 15, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 10, 2019ALIEASSIGNED TO LIE—
Oct 4, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2019RFNTREFUSAL PROCESSED BY IB—
May 18, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 18, 2019RFRRREFUSAL PROCESSED BY MPU—
Apr 24, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 23, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2019DOCKASSIGNED TO EXAMINER—
Apr 16, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 11, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance